3'-Trifluoromethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-carboxylic acid ethyl ester, 95.0%, 1g

5-Chloro-2-iodobenzamide, 95%, 5g

dNTP-Set 1, 5 x 4 x 25 µmol (250 µl), 100 mM

4-Methoxy-3-methylaniline, 99.0%, 1g

3-Hydroxypropionic acid, 30% in water, 95.0%, 1g

(1-Cyclohexylmethyl)piperazine, 97.0%, 25g

Ethyl oleate, 75%, 25g

2-(1H-Indol-5-yl)acetonitrile, 95.0%, 1g

2-Amino-6-fluoropyridine, 98.0%, 5g

6-Bromoquinazolin-2(1H)-one, 95.0%, 250mg

4-[(1,4-Diazepan-1-yl)sulfonyl]morpholine, 95.0%, 5g

2-Methyl-1-butanol, min. 97.5%, for synthesis, 500 ml, glass packaging

(8R,9S,13S,14S,17S)-3-Hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate, 95.0%, 100mg